medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2015, Número 617

<< Anterior Siguiente >>

Rev Med Cos Cen 2015; 72 (617)


Prevención secundaria del accidente vascular cerebral

López MRE

Idioma: Español
Referencias bibliográficas: 19
Paginas: 773-779
Archivo PDF: 369.86 Kb.


RESUMEN

El accidente vascular cerebral (A.V.C.) es una entidad que afecta de manera importante la calidad de vida del paciente, por ello un abordaje integral e intenso es esencial para evitar las recidivas de este padecimiento, las cuales pueden deshabilitar más la funcionalidad del paciente así como provocar eventos mortales. El autor resume las últimas tendencias acerca de su abordaje.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Bernstein, Richard; Acute Stroke Intervention - A Systematic Review. JAMA, April 14 2015- Volume 313 Number 14

  2. Brott T., Adam; Olinger CP; Acute Ischemic Stroke. N Engl J Med 2007; 357:572-9

  3. Ciccone, A.; Mori, E.; Endovascular treatment for acute ischemic stroke. N Engl J Med 2013;368:2433-2434

  4. Cobb, Brian, Escuro AA, Celestin J, Kirby DF. Nutrition in the stroke patient. Nutr Clin Pract. 2011;26(3):242-52

  5. Corrigan ML; Markovic, John; Impact on healthy lifestyle on all cause and cardiovascular mortality after stroke in USA. J Neurol Neurosurg Psychiatry 2012;42:227-76

  6. Davis, Stephen; Donnan, Geoffrey; Secondary Prevention after Ischemic Stroke or Transient Ischemic Attack. N Engl J Med 2012;366:1914-22

  7. Diener, HC; ; Collaborative Metaanalysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. EMJ 2012;324:71-86

  8. Forbes, C. Aspirin at any dose above 30 mg offers only modest protection after cerebral ischemia. J Neurol Neurosurg Psychiatry 2006;60:197-6

  9. Goldstein LB; Hermansson, Karin. Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke. N Engl J Med 2008;359:12

  10. Gorelick, Philip. Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria. Stroke 2012;32:1091-8

  11. PRoFESS. Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med 2008,359:1225-37

  12. PROGRESS Collaborative Group. Randomized trial of a perindopril-based blood pressurelowering regimen among 6105 individuals with previous stroke or transient ischemic attack. Lancet 2011;358:1033-41

  13. Progue, J.; Sivenius, J. Effects of an angiotensin converting enzime inhibitor, ramipril, on cardiovascular events in high risk patients. N Engl J Med 2008;342:145-33

  14. Sleight, P; Vinisko, Richard. Level of Systolic Blood Pressure Within the Normal Range and Risk of Recurrent Stroke. JAMA, September 2011-Vol. 306, Number 19

  15. Smulyan, H. ACCORD-BP Study Group - Intensive blood pressure control in secondary prevention of stroke. Stroke;2003:34:2741-2748

  16. Szarek, M. Effects of cholesterol with simvastatin on stroke and other major vascular events and high risk conditions. Lancet 2004;363:757-67

  17. Thomson, J.; Reto, PS. Hemorrhagic Stroke in the Stroke Prevention by Aggressive Reduction in cholesterol Levels (SPARCL) trial. Stroke 2007;38:3198-204

  18. van Limbeek, J. Motor recovery after Stroke: a systematic review. Arch Phys Med Rehabil 2002;83:1629-37

  19. Zi An Pan. Depression and Risk of Stroke Morbidity and Mortality. JAMA September 21,2011. Vol 306, Number 11.




2020     |     www.medigraphic.com